Patrick C May Selected Research

Patrick C May Research Topics

23	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 07/2003
2	Amyloid Plaque 07/2009 - 07/2003
1	Memory Disorders (Memory Loss) 03/2016
1	Cognitive Dysfunction 03/2016
1	Skin Neoplasms (Skin Cancer) 10/2014
1	Weight Loss (Weight Reduction) 10/2014
1	Infections 10/2014
1	Neoplasms (Cancer) 05/2009
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2005
1	Astrocytoma (Pilocytic Astrocytoma) 02/2004

11	Amyloid beta-PeptidesIBA 01/2021 - 07/2003
9	Peptides (Polypeptides)IBA 03/2016 - 07/2003
5	Pharmaceutical PreparationsIBA 01/2021 - 09/2006
5	Amyloid (Amyloid Fibrils)IBA 01/2015 - 07/2003
5	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2014 - 05/2009
4	EnzymesIBA 01/2022 - 01/2012
4	Proteins (Proteins, Gene)FDA Link 07/2009 - 07/2003
2	N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamideIBA 10/2014 - 07/2009
1	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	IsotopesIBA 07/2009
1	Gamma Secretase Inhibitors and ModulatorsIBA 11/2007
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2006
1	Apolipoproteins E (ApoE)IBA 02/2004
1	Liver X ReceptorsIBA 02/2004
1	LigandsIBA 02/2004
1	Retinoid X Receptors (Retinoid X Receptor)IBA 02/2004
1	Messenger RNA (mRNA)IBA 02/2004
1	Y 27632IBA 11/2003

2	Therapeutics 01/2012 - 05/2009
1	Immunotherapy 01/2005